Mds Podcast
Targeting alpha synuclein in early Parkinson's disease. Clinical trials and future perspectives
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:00:00
- Mas informaciones
Informações:
Sinopsis
Two clinical trials with antibodies targeting alpha synuclein in early Parkinson's disease have been published in the New England Journal of Medicine. Anthony Lang and Gennaro Pagano, the first authors of the articles share the results and discuss the possible future perspectives with the MDS Podcast editor, Michele Matarazzo. Read the prasinezumab article. Read the cinpanemab article.
